Skip to Content
Merck
CN

A5575

Methyl δ-aminolevulinate hydrochloride

≥98% (TLC)

Synonym(s):

5-Amino-4-oxopentanoic acid methyl ester, 5-Aminolevulinic acid methyl ester

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C6H11NO3 · HCl
CAS Number:
79416-27-6
Molecular Weight:
181.62
NACRES:
NA.26
PubChem Substance ID:
24890995
UNSPSC Code:
12352209
EC Number:
279-151-1
MDL number:
MFCD00012868

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Methyl δ-aminolevulinate hydrochloride, ≥98% (TLC)

InChI key

UJYSYPVQHFNBML-UHFFFAOYSA-N

InChI

1S/C6H11NO3.ClH/c1-10-6(9)3-2-5(8)4-7;/h2-4,7H2,1H3;1H

SMILES string

Cl.COC(=O)CCC(=O)CN

assay

≥98% (TLC)

form

powder

color

white

storage temp.

2-8°C

Quality Level

200

Looking for similar products? Visit Product Comparison Guide

Related Categories

Biochem/physiol Actions

Methyl δ-aminolevulinate (methyl-ALA, MAL) and 5-Aminolevulinic acid (5-ALA) are commonly used in photosentizer reagents for photodynamic therapy to treat conditions such as Acne vulgaris and hypertrophic scarring.

pictograms

Exclamation mark
GHS07

signalword

Warning

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCH8764
BCBT8256
BCBT2003
BCBM7733V
BCBJ7699V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Nicola Bruscino et al.
Photodermatology, photoimmunology & photomedicine, 27(6), 334-335 (2011-11-19)
The case we report is about a female patient, 69 years old, who had a hypertrophic scarring on the right cheek because of a bite by her dog. She had attempted many types of topical and intralesional treatments but without
Yoojin Lee et al.
Seminars in cutaneous medicine and surgery, 30(4), 199-209 (2011-11-30)
Photodynamic therapy (PDT) involves the activation of a photosensitizing drug, which preferentially localizes to diseased skin, by irradiation with light to cause selective cytotoxic damage. Since its discovery in the early 20th century and the development of topical photosensitizers 2
Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part I. Acne vulgaris: when and why consider photodynamic therapy?
Sakamoto FH, Lopes JD, Anderson RR.
Journal of the American Academy of Dermatology, 63, 193-194 (2010)
Hui-Lin Ding et al.
Photodiagnosis and photodynamic therapy, 8(4), 343-346 (2011-11-30)
Acne vulgaris is a common dermatological disorder. Topical photodynamic therapy (PDT)-mediated with aminolevulinic acid (ALA) or methyl aminolevulinic acid (MAL) has been successfully used in the treatment of moderate to severe acne. The purpose of this case report is to
Romualdas Rudys et al.
Journal of biomedical optics, 20(5), 051035-051035 (2015-02-13)
This study combines several fluorescence detection methods to distinguish structural features of the synovium and cartilage tissues and to visualize the localization of endogenous porphyrins in the sensitized tissues. Specimens of synovium and cartilage tissues obtained from rabbits with antigen-induced

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service